SavedAdd your journal

Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2011 / Cilt: 25 - Sayı: 1

Multiple myelomlu hastada gelişen malign plevral effüzyon

Malign pleural effusion ın a patient with multiple Myeloma

Abdullah KATGI
Selda KAHRAMAN
Pınar ATACA
Özden PİŞKİN
Mehmet Ali ÖZCAN
G. Hayri ÖZSAN
Fatih DEMİRKAN
Bülent ÜNDAR
Pages
43–45
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper we mentioned about a 49 year old multiple myeloma patient in her fourth month of the diagnosis with a formation of malign pleural effusion just after induction chemotherapy and died because of respiratory failure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malign pleural effusion is a late and rare complication of multiple myeloma revealing the progression.
📊
Key Findings & Data:The mean survival time is four months after the diagnosis with a poor response to systemic chemotherapy.
💡
Conclusion & Impact:In this paper we mentioned about a 49 year old multiple myeloma patient in her fourth month of the diagnosis with a formation of malign pleural effusion just after induction chemotherapy and died because of respiratory failure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malign pleural effusion is a late and rare complication of multiple myeloma revealing the progression. The mean survival time is four months after the diagnosis with a poor response to systemic chemotherapy. In this paper we mentioned about a 49 year old multiple myeloma patient in her fourth month of the diagnosis with a formation of malign pleural effusion just after induction chemotherapy and died because of respiratory failure.

Özet

Malign plevral effüzyon, multiple myelomda progresyonla karekterize ve geç gelişen bir komplikasyondur. Tanıdan sonra ortalama yaşam süresi 4 aydır ve sistemik kemoterapilere oldukça dirençlidir. Biz bu makalede 49 yaşında tanıdan 4 ay sonra malign plevral effüzyon gelişen ve solunum yetmezliği nedeniyle kaybedilen bir hastayı sunuyoruz.

🔖

Cite This Article

KATGI, A., KAHRAMAN, S., ATACA, P., PİŞKİN, Ö., ÖZCAN, M. A., ÖZSAN, G. H., DEMİRKAN, F., ÜNDAR, B. (2011). Multiple myelomlu hastada gelişen malign plevral effüzyon. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 25 - Sayı: 1, 43–45. https://ajindex.com/articles/181314

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kyle RA, Rajkumar SV. Multiple myeloma; in Goldman L, Ausiello DA (eds): Cecil Textbook of Medicine, ed 22. Philadelphia, Saunders, 2004;1184–1195
  2. John CH, May LV. Pleural effusion in multiple myeloma. Cancer 1979;44: 1150-1154
  3. Meoli A, Willsie S, Fiorella R. Myelomatous pleural effusion. South Med J 1997; 90: 65–68
  4. Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol 2000; 22: 147–151
  5. Alexandrakis MG, Passam FH, Kyriakou DS and Bouros D. Pleural effusions in hematologic malignancies. Chest 2004;125:1546 – 1555
  6. VSS Attili, VP Singh, S Sundar, et al. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-596
  7. Abbate SL, Jaff MR, Fishleder AJ, et al. Lambda light chain myeloma with pleural involvement. Cleve Clin Med 1991;58:235-239
  8. Kim YJ, Kim SJ, Min K, et al. Multiple Myeloma with Myelomatous Pleural Effusion: A Case Report and Review of the Literature. Acta Haematol 2008;120:108–111
  9. Gogia A, Agarwal PK, Jain S, Jain KP. Myelomatous Pleural Effusion. J Assoc Physicians India 2005;53:734-736
  10. Kamble R, Wilson CS, Fassas A. Malignant pleural effusion of myeloma: Prognostic factors and outcome. Leuk Lymph 2005;46:1137-1142.